Online Trial Tracker - Larvol Sigma

Iqirvo (elafibranor) / Ipsen, Genfit

Phase N/A

Welcome, Profile Billing Logout

1 Trials

All TrialsIndustry lead sponsorIndustry collaboratorPhase N/A

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Iqirvo (elafibranor) / Ipsen

ELFINITY, NCT06447168: A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

Not yet recruiting

N/A

424

Ipsen

Primary Biliary Cholangitis

07/29

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites